Baxter International BAX announced longtime CEO Joe Almeida would be retiring immediately, without a successor in place, ...

Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With medical utilization rising, ...

Baxter International’s longtime CEO and board chair José Almeida is stepping down and retiring, effective immediately, the ...

Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and ...

During the election, Donald Trump promised the “mass deportation” of illegal immigrants. We’re just beginning to see what ...

I critique Baxter International's capital allocation decisions, stating the stock is not suitable for popular investment strategies. See why I rate BAX a sell.

Centerview Partners LLC and Evercore Inc. are serving as financial advisors and Cleary Gottlieb Steen & Hamilton LLP is serving as legal advisor to Henry Schein. Kirkland & Ellis LLP is serving as ...